Vue.component('pdc-ms-overview', { template: '
' + '' + '

Adherence to Non-Infused Disease-Modifying Agents Used to Treat Multiple Sclerosis (PDC-MS)

' + '
' + '' + '

Description

' + '
' + '' + '

The percentage of individuals 18 years and older who met the Proportion of Days Covered (PDC) threshold of 80% during the measurement year for disease-modifying agents used to treat multiple sclerosis (MS).

' + '

A higher rate indicates better performance.

' + '
' + '' + '

Additional Information

' + '
' + '' + '' + '

Intended Use

' + '
' + '' + '

Performance measurement for health plans.

' + '
' + '
' + '' + '' + '

Data Sources

' + '
' + '' + '

Prescription claims data.

' + '
' + '
' + '' + '' + '

Denominator

' + '
' + '' + "

Individuals with ≥2 prescription claims for non-infused disease modifying agents used to treat MS on different dates during the treatment period and who received ≥56 cumulative days' supply of the medication during the treatment period.

" + '
' + '
' + '' + '' + '

Exclusions

' + '
' + '' + '

Use of infused Disease Modifying Agents for MS.

' + '
' + '
' + '' + '' + '

Numerator

' + '
' + '' + '

Individuals who met the PDC threshold of 80% during the measurement year.

' + '
' + '
' + '
' }); Vue.component('pdc-ms', { template: '
' + '' + /*'' + '' +*/ '



' + '
', props: { rationale: { default: false }, faqs: { default: false } } });